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During neural development, growing axons express specific
surface receptors in response to various environmental guidance
cues. These axon guidance receptors are regulated through in-
tracellular trafficking and degradation to enable navigating axons
to reach their targets. In Caenorhabditis elegans, the UNC-
5 receptor is necessary for dorsal migration of developing motor
axons. We previously found that MAX-1 is required for UNC-5–
mediated axon repulsion, but its mechanism of action remained
unclear. Here, we demonstrate that UNC-5–mediated axon repul-
sion in C. elegans motor axons requires both max-1 SUMOylation
and the AP-3 complex β subunit gene, apb-3. Genetic interaction
studies show that max-1 is SUMOylated by gei-17/PIAS1 and acts
upstream of apb-3. Biochemical analysis suggests that constitutive
interaction of MAX-1 and UNC-5 receptor is weakened by MAX-1
SUMOylation and by the presence of APB-3, a competitive inter-
actor with UNC-5. Overexpression of APB-3 reroutes the trafficking
of UNC-5 receptor into the lysosome for protein degradation. In
vivo fluorescence recovery after photobleaching experiments
shows that MAX-1 SUMOylation and APB-3 are required for
proper trafficking of UNC-5 receptor in the axon. Our results dem-
onstrate that SUMOylation of MAX-1 plays an important role in
regulating AP-3–mediated trafficking and degradation of UNC-
5 receptors during axon guidance.
axon guidance | MAX-1 SUMOylation | AP-3 complex | UNC-5 receptor |
C. elegans
Afunctional nervous system requires proper formation ofneuronal connections, which begins with axon guidance (1).
During this process, the growing axon is directed by various at-
tractive and repulsive environmental cues until its tip, called the
growth cone, reaches its final target. The guidance information is
received by receptors on the growth cone, triggering a series of
intracellular signals that move the axon in the correct direction.
The diversity of developing axonal connections is established
through dynamic regulation of environmental cues, surface re-
ceptors, and intracellular signaling networks (1, 2).
During dorsal guidance of developing motor axons in Caeno-
rhabditis elegans, the UNC-5 receptor is expressed on axonal
growth cones, which are then repelled by a gradient of UNC-6/
Netrin in the environment (3–5). Accumulating evidence suggests
that axon guidance requires proper trafficking and distribution of
the UNC-5 receptors and its coreceptors UNC-40/DCC (6–9).
We previously isolated max-1 (motor axon guidance-1) in a
forward genetic screen and showed that max-1 works with unc-5
to regulate repulsion of motor axons in C. elegans (10). A sub-
sequent genetic study in zebrafish also suggested that max-1
plays a role in regulating membrane localization of Ephrin3b
proteins, which provide guidance cues for the migration of in-
tersegmental venous endothelial cells during embryogenesis (11).
However, how max-1 functions in the growth cone during unc-5–
mediated axon repulsion is not clear. To address this issue, we
used yeast two-hybrid screens to identify molecules that interact
with MAX-1 and UNC-5.
The MAX-1–interacting protein GEI-17/PIAS1 is a SUMOy-
lation E3 ligase (12). Protein SUMOylation is a posttranslational
modification process that alters the activity, stability, and sub-
cellular localization of the substrate protein (13). The dynamic
and reversible features of SUMOylation make it an ideal bio-
chemical switch to modulate diverse cellular processes, including
segregation of chromosomes, repair of damaged DNA, regula-
tion of transcription and enzyme activities, and control of in-
tracellular trafficking (14, 15). SUMOylation is also involved in
various aspects of neural development, which include prolifera-
tion, differentiation, apoptosis, target selection, synaptogenesis,
and synaptic plasticity (16–21). Here we show that SUMOylation
also plays a role in axon guidance by demonstrating that MAX-
1 is a substrate of GEI-17/PIAS1 and that SUMOylation of
MAX-1 is essential for UNC-5–mediated axon repulsion.
Our screen also identified an UNC-5–interacting protein,
APB-3, the β subunit of the AP-3 complex, which is located in
the plasma membrane, Golgi complex, and endolysosomal
compartments. The AP-3 complex functions as an adaptor for
trafficking cargo proteins and mediating protein degradation
(22, 23). Studies in cultured neurons and in AP-3–deficient an-
imals showed that AP-3 is involved in synaptic vesicle formation
from tubular endosomes (24, 25) and may play a role in traf-
ficking proteins within neuronal processes (26, 27). A recent
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report in C. elegans further demonstrates that AP-3 is re-
quired for differential targeting of transmembrane proteins
into axons (28).
Here we report that UNC-5 interacts with APB-3 and that
SUMOylated MAX-1 requires APB-3 to affect UNC-5–mediated
axon repulsion. UNC-5 is degraded mainly in the endolysosomal
compartment when APB-3 is overexpressed, and the interaction of
UNC-5 and MAX-1 is significantly reduced in the presence of
APB-3. We also show that the trafficking of UNC-5 receptors in
axons requires SUMOylated MAX-1 and APB-3. Together, our
results suggest that MAX-1 SUMOylation and the AP-3 complex
play important roles in regulating the trafficking and degradation
of UNC-5 receptors during axon guidance.
Results
GEI-17/PIAS1 and APB-3 Interact with MAX-1 and UNC-5, Respectively.
In a yeast two-hybrid screen using the C terminus of mouse
MAX-1 ortholog as bait (Fig. 1A), we isolated 16 independent
positive colonies. Among these, two encoded fragments of
mouse protein inhibitor of activated STAT-1 (PIAS1). The in-
teraction of MAX-1 and PIAS1 was confirmed by coimmuno-
precipitation from cotransfected COS cell lysates (Fig. 1B) and
by pull-down of GST-tagged C. elegans MAX-1 with in vitro-
purified C. elegans PIAS1 ortholog, GEI-17 (Fig. 1C). PIAS1
contains an SAF-A/B, acinus, and PIAS (SAP) domain in the N
terminus, a really interesting new gene (RING) finger domain in
the middle, and a less-conserved C terminus. Domain mapping
showed that the N-terminal half, which includes SAP and RING
domains, is necessary and sufficient for PIAS1’s interaction with
MAX-1 (Fig. 1D). The direct binding of MAX-1 to GEI-17/
PIAS1 suggests MAX-1 could be a SUMOylation substrate
regulated by GEI-17/PIAS1.
The cytoplasmic region of UNC-5 contains a zona pellucida
UNC-5 (ZU5) domain, a DCC-binding (DB) domain, and a
death domain (DD) (Fig. 1E). Because bait consisting of the
entire UNC-5 cytoplasmic domain was self-activating, only the
ZU5 domain was used as bait (labeled as UNC-5-ZU5) in
the yeast two-hybrid screen for UNC-5 interacting molecules,
which identified APB-3, the β subunit of AP-3 complex. Binding
of UNC-5 with APB-3 into a protein complex was confirmed
by coimmunoprecipitation and subcellular colocalization in
cotransfected COS cells (Fig. 1F and SI Appendix, Fig. S1A) and
by in vitro GST pull-down assay (Fig. 1G). Mapping for protein–
protein interaction sites further revealed that a potential AP-
binding dileucine motif of the ZU5 domain is responsible for
UNC-5’s binding with APB-3 (Fig. 1H). Given that APB-3 is an
essential subunit of the tetrameric AP-3 complex, which regu-
lates the sorting of vesicles mainly in the endolysosomal pathway
(27, 29), the interaction of UNC-5 with APB-3 suggests that
UNC-5 could be a cargo regulated by AP-3 for some sort of
intracellular vesicular trafficking.
gei-17 Functions Upstream of max-1 to Regulate unc-5–Mediated
Axon Repulsion. In C. elegans, gei-17 is involved in various cellu-
lar processes, including chromosome congression and telomere
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Fig. 1. Isolation of GEI-17/PIAS1 and APB-3 as MAX-1– and UNC-5–interacting proteins, respectively. (A) Schematic diagrams of the full-length mouse MAX-
1 and the bait for yeast two-hybrid screen. MAX-1 contains two PH domains, an MyTH4 domain, and a FERM domain. The bait consists of LexA fused to the C
terminus of MAX-1. FERM, band 4.1/ezrin/radixin/moesin; MyTH4, myosin tail homology 4; PH, pleckstrin homology. (B) Immunoblots show that GFP-MAX-
1 coimmunoprecipitates with PIAS1. In comparison, GFP-mock did not form protein complex with PIAS1. (C) The C terminus of MAX-1, but not the N terminus,
binds directly to GEI-17 in the GST pull-down assay. Note that the loading input is 5% of the total protein lysate. (D) Domain mapping by yeast two-hybrid
assay indicates that the N-terminal half of PIAS1, which includes SAP and RING finger domains, is required for its interaction with MAX-1. Shown is a strip of
representative X-gal reactions for yeast cells transformed with the indicated construct prey plus the MAX-1 C terminus bait. RING, really interesting new gene;
S/T, serine- and threonine-rich; SAP, SAF-A/B, acinus and PIAS. (E) Schematic diagrams of the cytoplasmic region of UNC-5 and the ZU5 bait for yeast two
hybrid screen. DB, DCC-binding; DD, death domain; ZU5, zona pellucida UNC-5. (F) APB-3, not the mock-control, is detected in the protein complex
immunoprecipitated by MYC-tagged UNC-5. Asterisks indicate the mCherry-mock and mCherry-APB-3 bands in the lysates. (G) The cytoplasmic region of UNC-
5 binds directly to the purified APB-3 in the in vitro GST pull-down assay. The loading input is 5% of the total protein lysate and the GST-UNC-5 cytoplasmic
band in the input is indicated by an asterisk. (H) Domain mapping by yeast two-hybrid assay shows the UNC-5 ZU5 domain is sufficient for its interaction with
APB-3. Mutations of both amino acids L(524)I(525) to A(524)A(525) in the ZU5 domain (asterisk) disrupt the interaction. A representative strip of X-gal re-
actions is shown for yeast cells transformed with indicated UNC-5 cytoplasmic construct tagged with LexA plus APB-3 full-length fused to GAL4AD.
Chen et al. PNAS | vol. 115 | no. 35 | E8237
D
EV
EL
O
PM
EN
TA
L
BI
O
LO
G
Y
position in early embryos, DNA damage response, and devel-
opment of pharyngeal muscle (30–33). However, whether GEI-
17 functions in the development of the C. elegans nervous system
has not been investigated. We showed that transgenic gei-17
promoter GFP was expressed in the developing and adult C.
elegans motor neurons, which started as early as the threefold
stage (Fig. 2A and SI Appendix, Fig. S1B). In addition, mild
motor axon guidance defects were observed in a gei-17 mutant
(tm2723) or a worm with gei-17 RNAi knockdown (Fig. 2 B and
C), indicating that gei-17 plays a role in axon guidance.
We previously showed that max-1 and max-2 acted via parallel
rac-independent and -dependent genetic pathways in UNC-5–
mediated axon repulsion (34–36). Genetic interaction analysis
revealed that gei-17 did not enhance max-1’s axon guidance de-
fect in max-1;gei-17 double mutants, but max-2’s defect was
dramatically enhanced by gei-17 in max-2;gei-17 double mutants
(Fig. 2C). This finding suggests gei-17 is likely to act in the max-
1–mediated pathway, but in parallel to the rac-dependent path-
way involving genes like max-2 and ced-10 (34). Taking advan-
tage of this result, we performed several rescue and enhancement
experiments in a sensitized background using rac pathway mu-
tants such as max-2 or ced-10 to significantly enhance the axon
guidance defects of gei-17, which was relatively weak by itself (SI
Appendix, Fig. S1C). In the sensitized max-2 mutant background,
the defects caused by gei-17 RNAi knockdown were significantly
rescued by expressing a gei-17/PIAS1 cDNA specifically in motor
axons under the unc-25 promotor (Fig. 2D). This result indicates
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Fig. 2. C. elegans gei-17 plays a role in the dorsal guidance of motor commissural axons. (A) gei-17 is expressed in developing ventral cord motor neurons. At
L1 stage, monomeric RFP driven by unc-25 promoter is expressed strongly in DD neurons. GFP expression driven by the gei-17 promoter is observed in the
same neurons. Anterior is to the left and dorsal is up. (Scale bar: 5 μm.) (B) Some motor commissural axons are misguided in gei-17(tm2723)mutants (arrow) in
the juIs76[Punc-25::GFP] background. (Scale bars: 20 μm.) (C) Quantification of axon guidance defects in gei-17, max-1, and max-2 mutants. gei-17 mutants
exhibit mild guidance defects, and the mutation does not enhance effects of the max-1 mutation. However, the defects of max-2 mutants are significantly
enhanced by the gei-17 mutation. (D) Quantification of genetic interactions between gei-17 and max-1 with or without SUMOylation. SUMOylation mimetic
WT max-1 cDNA (Ex Punc-25::MAX-1::SMO-1) is able to rescue the axon guidance defects enhanced by RNAi knockdown of gei-17 in a max-2(cy2)-sensitized
background. Mammalian PIAS1 (Ex Punc-25::PIAS1) cell-autonomously rescues the defects enhanced by RNAi knockdown of C. elegans gei-17. RNAi
knockdown of NIL or col-86 served as controls. eri-1(mg366) enhances RNAi effect in neurons. (E) RNAi knockdown of each known gene involved in the
SUMOylation pathway in C. elegans by soaking. Knocking-down of any of these genes significantly enhances the defects caused bymax-2mutant. For C–E, n =
21–64. Error bars indicate SEMs. n.s., no significant difference by Student’s t test; *P < 0.05; **P < 0.01; ***P < 0.001.
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that gei-17/PIAS1 is involved in axon repulsion in a cell-
autonomous manner.
Because GEI-17 is a SUMOylation E3 ligase, we next asked if
MAX-1 was its substrate by testing whether the defects caused by
gei-17 knockdown were rescued by SUMOylated MAX-1. The
function of a SUMOylated protein can be mimicked by fusing
SUMO protein to its C terminus (37–39). We generated a
SUMOylation mimetic max-1 construct by fusing the C. elegans
SUMO gene smo-1 to max-1 (max-1::smo-1). In the max-2 mu-
tant background, expressing the SUMOylation mimetic max-1,
but not the WT max-1, significantly suppressed the axon guid-
ance defect caused by gei-17 RNAi knockdown (Fig. 2D), sug-
gesting that SUMOylated MAX-1 can bypass the requirement
for gei-17 in axon repulsion. Accordingly, we conclude that gei-17
acts upstream of max-1 in axon guidance by facilitating MAX-1
SUMOylation.
SUMOylation of MAX-1 Is Required in UNC-5–Mediated Axon
Repulsion. In addition to the specific substrate-recognition
E3 ligases, the common components of SUMOylation pathway
in C. elegans include the SUMO gene smo-1, the E1-activating
enzymes uba-2 and aos-1, and the E2 conjugating enzyme ubc-
9. Using RNAi to eliminate any of these SUMOylation path-
way component genes results in embryonic lethality (37, 40).
To address whether the SUMOylation pathway is involved in
motor axon guidance, we performed a weak RNAi knockdown
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Fig. 3. SUMOylation of MAX-1 is required for its function in the guidance of motor commissural axons in C. elegans. (A) A schematic diagram of candidate
SUMOylation sites of C. elegans MAX-1 protein predicted by SUMOplot. FERM, band 4.1/ezrin/radixin/moesin; MyTH4, myosin tail homology 4; PH, pleckstrin
homology. (B and C) Quantification of the ability of MAX-1 SUMOylation site mutant variants to rescue the axon guidance defects in sensitized max-1;ced-10
mutant background. Amino acid K-to-R mutations of the predicted SUMOylation sites were introduced into max-1 cDNA under unc-25 promoter. These
mutant max-1 cDNA constructs were injected into max-1;ced-10 double-mutant worms to assess their ability to rescue the axon-guidance defects. Among all
single SUMOylation site mutations, onlymax-1(K476R) andmax-1(K784R) are unable to fully rescue the defects as WT max-1 (B). The failure-to-rescue effects
of max-1(K476R) or max-1(K784R) can be restored by SUMOylation mimetic max-1(K476R)::smo-1 or max-1(K784R)::smo-1 but not by ubiquitination mimetic
max-1(K476R)::ubq-1 ormax-1(K784R)::ubq-1 (B). Multiple K-to-R mutations (up to all six) of the predicted SUMOylation sites do not change the effects caused
by max-1(K476R) or max-1(K784R) single mutation (C). The SUMOylation mimetic max-1(K476R)(K784R)::smo-1, but not the ubiquitination mimetic max-1
(K476R)(K784R)::ubq-1, can rescue the defects as does the max-1 WT (C). Shown here are combined data from at least three independent generated
transgenic lines. The defects were quantified and compared using transgenic animals and their nontransgenic siblings. n = 26–56. Error bars indicate SEMs.
n.s., no significant difference by Student’s t test; ***P < 0.001. (D–F) Immunoblots of in vitro SUMOylation reactions of the recombinant proteins GST-MAX-1
(330–1099), GST-MAX-1(330–616), and GST-MAX-1(550–1099). MAX-1 is SUMOylated in vitro in a GEI-17 concentration-dependent manner (D). The
SUMOylated GST-MAX-1(330–1099) proteins (indicated by a bracket) are not present without E1 and E2 ligase enzyme or with a SUMO-specific protease SENP-
1 (D). K476R mutation in GST-MAX-1(330–616) attenuates SUMOylation of GST-MAX-1 fusion proteins; the bracket indicates SUMOylated GST-MAX-1(330–
616) proteins (E). K784R mutation in GST-MAX-1(550–1099) does not attenuate SUMOylation of GST-MAX-1 fusion proteins; the bracket indicates SUMOy-
lated GST-MAX-1(550–1099) proteins (F). Arrowheads in all panels indicate un-SUMOylated GST-MAX-1 fusion proteins. rxn, reaction.
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by soaking worms in diluted double-stranded RNA to avoid le-
thality. In the sensitized max-2 mutant background, weak RNAi
knockdown of any of the SUMOylation pathway component genes
significantly enhanced the axon-guidance defect caused by max-2
mutation alone (Fig. 2E). While further cell-autonomous experi-
ments are necessary to demonstrate direct regulations of these
SUMOylation pathway genes, these data together are consistent
with the idea that the SUMOylation pathway is involved in motor
axon guidance.
Six lysine residues in the MAX-1 protein are predicted to be
SUMOylation sites (www.abgent.com/sumoplot) (Fig. 3A). To
determine which of these lysine residues are important for its
function, we generated various max-1 cDNA mutant constructs
with lysine (K) mutated to arginine (R) at these candidate sites.
Each mutant’s function was then evaluated in a sensitized max-1;
ced-10 double-mutant background (35). WT max-1 rescued the
axon guidance defect of the max-1;ced-10 double mutant by re-
ducing the 70% failure rate to 20%. Among the six max-1 con-
structs with a single K-to-R mutation, only max-1(K476R) or
max-1(K784R) was unable to significantly rescue the defects,
compared with WT or other mutants (Fig. 3B). However, the
SUMOylation mimetic max-1(K476R)::smo-1 or max-1(K784R)::
smo-1 regained the ability to rescue the defects as the WT max-1
did, indicating that K476R or K784R is essential for MAX-1
SUMOylation (Fig. 3B). As a control, the max-1(K476R) or
max-1(K784R) fused with the C. elegans ubiquitin gene ubq-1 did
not have the same effects (Fig. 3B). Interestingly, multiple point
mutation constructs from double up to sextuple did not further
change the effects observed in either K476R or K784R alone
(Fig. 3C). These results together indicate that K476 and
K784 are required for MAX-1–mediated axon guidance, and that
these two sites are in the same SUMOylation genetic pathway.
An in vitro SUMOylation assay on GST-fused MAX-1 peptide
[amino acid residue 330–1099; labeled as GST-MAX-1(330–
1099)] confirmed that MAX-1 was SUMOylated in the presence
of GEI-17 in a concentration-dependent manner and this
SUMOylation effect was eliminated by adding the SUMO-
specific protease SENP-1 (Fig. 3D). When GST-MAX-1(330–
1099) was further split into two peptides—GST-MAX-1(330–
616), which contains K476, and GST-MAX-1(550–1099), which
contains K784—both could be SUMOylated in vitro (Fig. 3 E
and F). However, when the MAX-1 peptide with either K476R
or K784R mutation was tested, SUMOylated MAX-1(K476R)
peptide was undetectable (Fig. 3E), but SUMOylated MAX-1
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Fig. 4. The axon guidance mediated by SUMOylated MAX-1 requires apb-3. (A) apb-3 is expressed in developing ventral cord motor neurons. At L1 stage, the
Papb-3::GFP (green) is coexpressed with monomeric RFP driven by unc-25 promoter (red) in DD neurons. (Scale bar: 5 μm.) Anterior is to the left and dorsal is
up. (B) Quantification of axon guidance defects in apb-3, max-1, and max-2 mutants. apb-3 mutant by itself does not show axon-guidance defects, but it
significantly enhances the defects of the max-2, but not the max-1, mutant. The apb-3;max-2 defects can be cell-autonomously rescued by Punc-25::APB-3::
GFP. (C) Representative images of motor commissural axon-guidance defects observed in apb-3;max-2 (Upper images) and apb-3;max-1 (Lower image) double
mutants. Defects are indicated by arrowheads. (Scale bars: 20 μm.) (D) Quantification of axon-guidance defects caused by RNAi knockdown of each com-
ponent of C. elegans AP-3 complex in the sensitized max-2 mutant background. RNAi knockdown of each of these genes, which include genes encoding β
(apb-3), δ (apd-3), μ (apm-3), and σ (aps-3) subunits, significantly enhances the defects caused by max-2 mutant alone. eri-1(mg366) enhances RNAi effect in
neurons; col-86 is a control. (E) Quantification of genetic interactions between apb-3 and SUMOylated MAX-1. max-1(K476R)(K784R) and SUMOylation
mimetic max-1(K476R)(K784R)::smo-1 were expressed in sensitized max-1;ced-10 double-mutant background under unc-25 promoter. The transgenic animals
were then crossed into apb-3 mutants to generate max-1;ced-10;apb-3 triple mutants. The defects were quantified and compared using the transgenic
animals and their nontransgenic siblings. For B, D, and E, n = 36–64. Error bars indicate SEMs. n.s., no significant difference by Student’s t test; *P < 0.05; **P <
0.01; ***P < 0.001.
E8240 | www.pnas.org/cgi/doi/10.1073/pnas.1804373115 Chen et al.
(K784R) peptide was still present (Fig. 3F), suggesting that
K476 amino acid is the primary SUMO acceptor site of MAX-
1 protein. Taken together, these data suggest that GEI-17 can
SUMOylate MAX-1 at specific lysine sites and such GEI-17–
mediated SUMOylation of MAX-1 is required for the function
of MAX-1 in regulating dorsal guidance of motor axons.
apb-3 Functions Downstream of max-1 to Regulate unc-5–Mediated
Axon Repulsion. We found that apb-3 was also expressed in
C. elegans motor neurons (Fig. 4A). Although the apb-3(ok429)
mutant did not exhibit an obvious axon guidance defect, it sig-
nificantly enhanced the defect in max-2 but not in max-1 mutants
(Fig. 4 B and C), suggesting that apb-3, like gei-17, functions in the
max-1–mediated signaling pathway. This max-2 phenotype en-
hancement caused by apb-3 mutant was rescued by the expression
of a WT apb-3 cDNA driven by the motor neuron-specific unc-25
promoter (Fig. 4B). Thus, apb-3 is cell-autonomously involved in
the max-1–mediated signaling pathway in motor neurons. AP-3 is
a heterotetrameric complex composed of β, δ, μ, and σ subunits
(27). In addition to apb-3 (the β subunit gene), RNAi knockdown
of δ subunit gene apd-3, μ subunit gene apm-3, or σ subunit aps-3
similarly enhanced the defect of max-2 mutant, suggesting that
AP-3 complex is involved in the motor axon guidance (Fig. 4D).
To determine the genetic epistasis between apb-3 and max-1,
we crossed apb-3(ok429) into max-1;ced-10 double mutants
expressing either MAX-1 SUMOylation mutant MAX-1(K476R)
(K784R) or SUMOylation-mimetic MAX-1(K476R)(K784R)::
SMO-1 (Fig. 4E). As shown earlier (Fig. 3C), MAX-1(K476R)
(K784R) could only partially rescue the defects in the max-1;ced-
10 double mutants, but the SUMOylation-mimetic MAX-1
(K476R)(K784R)::SMO-1 significantly suppressed the defects,
producing a similar phenotype to WT MAX-1. By contrast, in
the apb-3;max-1;ced-10 triple mutant, the SUMOylation-mimetic
MAX-1(K476R)(K784R)::SMO-1 was unable to further sup-
press the defects compared with MAX-1(K476R)(K784R), in-
dicating that apb-3 is required for SUMOylated MAX-1 to
function properly. This effect was not due to the pleiotropic ef-
fect of apb-3, since apb-3 mutation did not enhance the defect of
max-1;ced-10 double mutant and transgenic animals expressing
MAX-1(K476R)(K784R) showed similar axon guidance defect with
or without apb-3 mutation (Fig. 4E). Collectively, these data dem-
onstrate that the APB-3–containing AP-3 complex acts downstream
of SUMOylated MAX-1 to regulate motor axon repulsion.
The UNC-5 Receptor Is Routed to Lysosomes by Overexpressing APB-3.
In cultured cortical neurons, UNC-5 was partially colocalized with
a trans-Golgi marker (TGN p230) and lysosome-associated
membrane protein 1 (LAMP-1). The AP-3 complex has pre-
viously been shown to reside in these organelles for cargo sorting
and degradation (SI Appendix, Fig. S2 A and B) (22, 27), sug-
gesting that UNC-5 might be degraded in the lysosome via AP-
3 complex. To explore this possibility, we turned to COS cells
where no endogenous MAX-1 or UNC-5 is expressed. The half-
life of the turnover of UNC-5 overexpressed in COS cells was
∼60 min, as determined by a cycloheximide-chase experiment
(Fig. 5A). Either the proteasome inhibitor MG132 or the lysosome
acidifier blocker bafilomycin A1 partially inhibited the degrada-
tion of UNC-5, suggesting that both the ubiquitin-proteasome
system and the lysosomal degradation pathway are involved in
the degradation of UNC-5 (Fig. 5B). Intriguingly, when UNC-
5 was coexpressed with APB-3 in COS cells, UNC-5 degradation
was accelerated. This effect depended on APB-3 concentration,
with UNC-5 degradation seeming to saturate at higher APB-
3 concentrations (Fig. 5C). In addition, when UNC-5 was coex-
pressed with APB-3, MG132 treatment no longer protected UNC-
5 from degradation. By contrast, lysosome blockers, either
BafA1 or NH4Cl, still inhibited UNC-5 degradation (Fig. 5D).
These data suggest that UNC-5 is preferentially routed to the ly-
sosomal degradation pathway in the presence of APB-3.
Interaction Between UNC-5 and MAX-1 Is Modulated by MAX-1
SUMOylation and APB-3. SUMOylation modifies protein’s surface
structure and can change its ability to interact with other proteins
(41). We previously reported that MAX-1 did not seem to in-
teract with UNC-5 (10). However, by adjusting the coimmuno-
precipitation condition, we were able to demonstrate that MAX-
1 did interact with UNC-5, as they reciprocally coprecipitated
each other in a protein complex (Fig. 6A). The previous negative
A
B
C
D
Fig. 5. Overexpression of APB-3 regulates UNC-5 degradation. (A) CHX (50
μg/mL) chase of UNC-5-MYC proteins transiently expressed in COS cells. Im-
munoblotting was performed with anti-MYC antibody to detect the amount
of UNC-5-MYC proteins and with anti–α-tubulin antibody to normalize the
loading amount. Bar graphs show the normalized ratio of UNC-5-MYC pro-
teins in each lane with the SD derived from seven replicate experiments.
(B) UNC-5-MYC–transfected COS cells were treated with CHX for 2 h in the
presence of MG132 (10 μM) or BafA1 (10 nM). Bar graphs show the normalized
ratio of UNC-5-MYC proteins from triplicate experiments. The P values were
estimated by one-way ANOVA with Holm–Sidak post hoc comparison. Both
MG132 and BafA1 treatments partially inhibit UNC-5 degradation. (C) Repre-
sentative immunoblots of protein lysates of COS cells cotransfected with UNC-
5-MYC and various amounts of mCherry-APB-3 after 1 h CHX chase. The line
graph shows results of seven replicates with the dots representing the average
value. Error bars indicated SDs. Overexpression of APB-3 enhances the deg-
radation of UNC-5 in a concentration-dependent manner. (D) Representative
immunoblots of protein lysates of COS cells cotransfected with UNC-5-MYC
and mCherry-APB-3 with or without MG132, BafA1, or NH4Cl (2 M) treatment
after 1 h CHX chase. The P values in bar graph were estimated by Mann-
Whitney rank sum test based on four independent experiments. Error bars
indicate SEMs. The lysosome acidifier blockers, BafA1 and NH4Cl, inhibit UNC-
5 degradation. By contrast, the proteasome inhibitor MG132 does not inhibit
UNC-5 degradation in the presence of APB-3. Normalized ratios in all panels
were calculated by comparing the intensities of each band estimated via
ImageJ to the intensity of the sample before chasing (left-most lane) after
normalization to the intensity of each respective α-tubulin band as a loading
control. *P < 0.05. BafA1, bafilomycin A1; CHX, cycloheximide; tx, treatment.
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result might have occurred because overexpressed MAX-1 is
modified by SUMOylation in COS cells, so that the interaction
was too unstable to detect. We tested this hypothesis by using
SUMOylation-mimetic MAX-1 and found that SUMOylated
MAX-1 significantly lost its binding affinity to UNC-5 (Fig. 6B).
Domain mapping analysis revealed that the ZU5 domain of
UNC-5, which is responsible for its interaction with APB-3 (Fig.
1H), also interacted with MAX-1 (SI Appendix, Fig. S3A), sug-
gesting that APB-3 might compete with MAX-1 for interaction
with UNC-5. Indeed, overexpressing APB-3 significantly in-
terfered with the binding of MAX-1 to UNC-5 (Fig. 6C). APB-
3 seemed to have higher affinity for UNC-5 than did MAX-1, as
a small amount of APB-3 expression is sufficient to achieve
maximal interference with UNC-5’s binding to MAX-1 (Fig. 6C).
We further demonstrated that using Brefeldin A to deplete the
insertion of AP-3 complex into intracellular vesicular membrane
increased colocalization of MAX-1 with UNC-5 in the cyto-
plasmic vesicles of transfected COS cells (SI Appendix, Fig. S3B)
and enhanced protein complex formation between MAX-1 and
UNC-5 despite the presence of APB-3 (Fig. 6D). This result
suggests that the AP-3 complex on the intracytoplasmic vesicles
can specifically interfere with binding between MAX-1 and UNC-
5. Together, these results indicate that the interaction between
UNC-5 and MAX-1 is modulated by MAX-1 SUMOylation and
by the level of AP-3 complex in the intracellular vesicles.
Genetic interaction analysis indicates max-1 is upstream of
apb-3 in regulating unc-5–mediated axon repulsion, which raises
the possibility that MAX-1 might mediate UNC-5 degradation
through APB-3. We found that MAX-1 and APB-3 did not in-
teract with each other biochemically (SI Appendix, Fig. S3D).
MAX-1 alone was degraded mainly through the endolysosomal
pathway, given that the lysosome blocker NH4Cl but not the
proteasome inhibitor MG132 prevented MAX-1 from degrada-
tion (SI Appendix, Fig. S3C). In addition, the turnover time of
UNC-5 was not affected by overexpressing MAX-1, SUMOyla-
tion mutant MAX-1(K476R)(K784R), or SUMOylation-mimetic
MAX-1 (SI Appendix, Fig. S2C). Likewise, the degradation of
MAX-1 was not affected by coexpressed UNC-5 either (SI
A
B
C D
Fig. 6. Biochemical interaction of MAX-1 and UNC-5 is modulated by MAX-1 SUMOylation and APB-3. (A) Immunoblots of lysates of cotransfected COS cells
show reciprocal coimmunoprecipitation of UNC-5 and MAX-1. (B) Representative immunoblots show the amount of SUMOylation mimetic MAX-1 in the UNC-
5 immunoprecipitate is significantly reduced (Upper). Likewise, less UNC-5 is immunoprecipitated by SUMOylation mimetic MAX-1 (Lower). For quantification,
the amount of each coimmunoprecipitate was normalized by the amount of the tagged protein immunoprecipitated by the indicated antibody. The nor-
malized amount was then adjusted to the input and compared with that of the MAX-1 SUMOylation mutant MAX-1(K476R)(K784R) to quantify the relative
fold change. The P values shown in the bar graph were estimated by one-way ANOVA with Holm–Sidak post hoc comparison from more than triplicate
experiments. Error bars indicate SDs. ***P < 0.001. (C) Immunoblots show that overexpression of APB-3 reduces the amount of MAX-1 proteins in UNC-
5 immunoprecipitates. Note that a relatively low amount of APB-3 overexpression is sufficient to achieve its maximal interference effect with the presence of
APB-3 in the UNC-5 immunoprecipitates. (D) Immunoblots show that Brefeldin A treatment (2 μg/mL) increases the amount of MAX-1 protein in UNC-
5 immunoprecipitates. Note that Brefeldin A treatment decreases the amount of endogenous APB-3 included in the immunoprecipitates.
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Appendix, Fig. S3E). These results suggest that, while UNC-
5 forms a protein complex with MAX-1, the degradation of
UNC-5 and MAX-1 in lysosomes is independently regulated.
Both SUMOylated MAX-1 and APB-3 Regulate UNC-5 Trafficking Along
the Axons. The AP-3 complex is involved not only in regulating
protein degradation but also in sorting and trafficking in-
tracellular vesicles (22, 23, 28, 42). To address how MAX-1 and
APB-3 regulate the trafficking of vesicles carrying UNC-5 re-
ceptor, we generated a transgenic line expressing monomeric
RFP-tagged UNC-5 (UNC-5::mRFP) in C. elegans motor axons.
As shown previously (8), UNC-5::mRFP accumulated as puncta
along the motor axons (Fig. 7A). In max-1 or apb-3 mutants,
punctated UNC-5::mRFP was still observed, indicating that
UNC-5 receptors were transported along axons in these mutants.
We then performed fluorescence recovery after photobleaching
(FRAP) experiments to access the dynamics of UNC-5 receptor
trafficking along axons. In unc-5 mutants that were rescued by
specifically expressing UNC-5::mRFP in motor neurons (pro-
ducing WT motor axons), 43% recovery of fluorescent intensity
was observed at 30 min after photobleaching (Fig. 7 B and C).
However, when these transgenic worms were in the max-1 mu-
tant background, the recovery was significantly reduced to 4%.
Similarly, in the transgenics under apb-3 mutant background,
only 9% recovery was observed (Fig. 7 B and C). Therefore, both
max-1 and apb-3 are involved in regulating the dynamics of
UNC-5 transportation along the axon in vivo.
We next performed FRAP in these transgenics under max-1
mutant background but expressing either max-1(K476R)(K784R)
or max-1(K476R)(K784R)::smo-1. As shown in Fig. 7 B and C,
max-1(K476R)(K784R)::smo-1 rescued the recovery rate of
fluorescent intensity significantly better than max-1(K476R)
(K784R) (32% vs. 6%; P = 0.029). Altogether, these data in-
dicate that the trafficking of UNC-5 receptor in the axon is
regulated by both SUMOylated MAX-1 and APB-3.
Discussion
SUMOylation of MAX-1 Regulates UNC-5–Mediated Axon Repulsion.
In this study, we identified the SUMOylation E3 ligase GEI-17/
PIAS1 as a regulator of MAX-1 and demonstrated that MAX-1
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Fig. 7. Regulation of UNC-5 receptor trafficking in C. elegans axons in vivo requires APB-3 and SUMOylated MAX-1. (A) Schematic diagrams to show the
punctated (red dots) expression pattern of UNC-5::mRFP in a C. elegans motor axon (Left) and the FRAP experimental procedures (Right). The approximate
axon segment shown in images in B is indicated in the boxed area. (B) Representative FRAP time-course images showing that the recoveries of UNC-5::mRFP
puncta after photobleaching (oval areas) are impaired inmax-1 and apb-3mutant backgrounds. The impaired recoveries of UNC-5::mRFP puncta in themax-1
mutant background are cell-autonomously rescued by SUMOylation mimeticmax-1 [MAX-1(K476R)(K784R)::SMO-1], but not by SUMOylation-mutatedmax-1
[MAX-1(K476R)(K784R)]. (Scale bar: 5 μm.) (C) The average FRAP recovery profiles from each set of experiments are shown as scattered line plots. The P values
shown at t = 30 min were calculated by one-way ANOVA with Holm–Sidak post hoc comparison. n ≥ 3. Error bars indicate SDs. *P < 0.05; **P < 0.01.
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SUMOylation is critical for UNC-5–mediated axon repulsion.
Detailed molecular, genetic, and biochemical analysis revealed that
MAX-1 acts as a dynamic regulator of the UNC-5 receptor: MAX-
1 constitutively binds to UNC-5 receptor in axons but dissociates
from UNC-5 when MAX-1 is SUMOylated. This dynamic switch
regulates the trafficking and degradation of UNC-5 receptor.
Our results show that SUMOylation of the conserved K476
amino acid in MAX-1 is essential for its function. Another amino
acid, K784, is also required for MAX-1’s function genetically, but
biochemical evidence suggests it is not a primary SUMO accep-
tor site. Because SUMOylation-mimetic MAX-1(K784R)::smo-
1 rescues the axon-guidance defect caused by max-1 mutation,
K784 might have a modulatory role in MAX-1’s function. Post-
translational modifications such as phosphorylation, ubiquitination,
and acetylation can modify a potential SUMO acceptor site to
change its SUMOylation status (13, 14). Such intramolecular
“cross-talk” between posttranslational modifications has been
reported for several SUMOylated proteins (13, 43, 44). It will
therefore be interesting to know how the SUMO acceptor sites of
MAX-1 are regulated by other posttranslational modifications.
Another important question to be addressed is how the
SUMOylation E3 ligase GEI-17 is activated. Our current data do
not provide information on the activation of GEI-17, although
we know that both the gei-17 gene and SUMOylation of MAX-
1 are required for normal function of UNC-5. It remains to be
investigated whether the signaling of the UNC-5 receptor acti-
vated by UNC-6 triggers the activation of GEI-17 and the sub-
sequent SUMOylation of MAX-1.
AP-3 Routes UNC-5 Degradation Through the Lysosomal Pathway and
Modulates UNC5 Trafficking Along the Axon. The AP-3 complex is
one of the intracellular coat protein complexes that function as
adaptors for vesicular sorting (23, 27, 29). We found that AP-
3 complex directs the UNC-5 receptor to the lysosomal pathway
for accelerated turnover. In cultured mammalian neurons, UNC-
5 receptors are internalized by endocytosis upon stimulation of
UNC-6 (6). We therefore envision that an increase in UNC-5–
containing vesicles sorted by AP-3 for degradation in lysosomes
can provide a mechanism for shutting down the UNC-5 signaling
activated by UNC-6 during axon guidance.
Our in vivo FRAP study suggests that the AP-3 complex is in-
volved in regulating the trafficking of UNC-5 receptor in axons,
which also requires SUMOylatedMAX-1. However, this approach
does not address the nature of UNC-5–associated vesicles and the
directionality of UNC-5 transportation along the axon. Neither
does it address whether the control of such trafficking is related to
UNC-5 degradation. Nevertheless, given our genetic data showing
apb-3 is required for max-1 to regulate UNC-5–mediated axon
repulsion, we suspect that AP-3 acts via degradation and protein
trafficking, as well as its coordination with MAX-1, in the dynamic
control of UNC-5 receptors during axon guidance.
The regulation of UNC-5 receptor by AP-3 complex is likely to
involve other molecular mechanisms. AP-3, like other AP
adaptor complexes, recognizes a conserved sorting motif, the
dileucine motif (D/E)XXXL(L/I), on vesicle cargo proteins and
facilitates the assembly and sorting of vesicles by binding the
vesicular trafficking machinery, such as BLOC-1 and HOPS (27).
Phosphorylated (S/T)XXXL(L/I) mimics the dileucine sorting
motif (D/E)XXXL(L/I) for binding adaptor protein complexes
(45–48). An (S/T)XXXL(L/I) motif can be identified in the
ZU5 domain of UNC-5 (amino acid 520–525). We demonstrate
here that the ZU5 domain binds APB-3 directly and that mu-
tations of the amino acids L(524)I(525) to A(524)A(525) disrupt
the interaction between UNC-5 and APB-3 (Fig. 1G). Thus, we
reason that, after phosphorylation, the (S/T)XXXL(L/I) motif
on the ZU5 domain of UNC-5 can function as an AP-3 binding
dileucine motif. As several protein kinases or phosphatases are
involved in UNC-5–mediated axon guidance (8, 9, 35, 49, 50), it
is likely that the interaction of AP-3 with UNC-5 is activated by
regulated phosphorylation.
A Model for SUMOylated MAX-1 and AP-3 in the Regulation of UNC-5
Receptors During Axon Repulsion. Previous studies have clearly
demonstrated that the ZU5 domain of UNC-5 receptor is crucial
for axon guidance (51–53). Here we show that MAX-1 and APB-
3 competitively bind the ZU5 domain of UNC-5 and together
they regulate the guidance of C. elegans motor axons. Geneti-
cally, max-1 acts upstream of apb-3 in the unc-5–mediated axon
repulsion. Both max-1 and apb-3 are required for UNC-
5 receptor trafficking in axons. In addition, our biochemical
analysis indicates that APB-3 has stronger binding affinity to
UNC-5 than does MAX-1 and that SUMOylated MAX-
1 weakens its binding with UNC-5. Although APB-3 facilitates
UNC-5 degradation, MAX-1, with or without SUMOylation,
does not affect the degradation of UNC-5 regulated by APB-3.
We therefore propose the following model (SI Appendix, Fig.
S4): MAX-1 is a dynamic regulator of UNC-5 receptor in the
axon. MAX-1 constitutively binds to UNC-5 receptor during ax-
onal development. When the SUMOylation E3 ligase PIAS1/GEI-
17 is activated, either through ligand binding to UNC-5 receptor
or via other unidentified mechanisms, MAX-1 is SUMOylated. As
a consequence, UNC-5 receptor is dissociated from SUMOylated
MAX-1, favoring more interaction between UNC-5 receptor and
other molecules such as APB-3. Thus, MAX-1 acts as a modula-
tory molecular switch to regulate UNC-5 receptor’s intracellular
interactions. In the presence of AP-3 complex, after dissociating
from SUMOylated MAX-1, UNC-5 receptor can be sorted for
trafficking in the axon and/or routed for endolysosomal degrada-
tion. Without MAX-1, as in the max-1 mutant, the trafficking and
degradation of UNC-5 receptors are dysregulated, resulting in
axon-guidance defects. Overexpressing unc-5, which presumably
provides more available surface UNC-5 receptors, can thus par-
tially rescue the axon guidance defects in max-1 mutants (10).
Guiding axons through concentration gradients of environ-
mental cues is an essential mechanism for forming a proper
neuronal connection network. During axon repulsion, the growing
axons migrate by sensing concentration differences of the guid-
ance cues. Because the concentration differences along the gra-
dient are constantly changing, the navigating growth cone has to
actively regulate its response so that it can move directly away
from the guidance cue (54, 55). Previous studies have demon-
strated regulated interactions of ligands (UNC-6 and UNC-129)
and receptors (UNC-5 and UNC-40) are essential for dorsal re-
pulsion of motor axons. The growth cone is initially repelled by a
high concentration of UNC-6 through UNC-5 receptor alone, but
when the growth cone moves dorsally and the concentration of
UNC-6 in the environment becomes low, the UNC-5 receptor
needs both UNC-129 and UNC-40 to properly guide the axons
(5). However, these studies did not address an alternative mech-
anism by which the UNC-5 receptor itself is regulated (56).
Lysosomal degradation of proteins can occur in the growth
cone locally (57). If UNC-6 binding to UNC-5 could trigger
PIAS1/GEI-17 activation, our model (SI Appendix, Fig. S4) could
provide a potential alternative for how UNC-5 receptor is reg-
ulated locally when the growth cone is moving away from the
UNC-6 gradient. Regulated degradation of surface receptors in
response to a morphogen concentration gradient would lead to a
dampened response downstream of the receptors in the high-
concentration morphogen field but a heightened response in
the low-concentration field (58). Consistent with this effect, our
model (SI Appendix, Fig. S4) predicts that the surface availability
of UNC-5 is increased at low UNC-6 concentration due to less
activation of PIAS1/GEI-17 and thus less UNC-5 degradation. In
addition, in a model predicting the variability and the reliability
of biological response toward a diffusible morphogen concen-
tration gradient (59), changes in available receptors would result
E8244 | www.pnas.org/cgi/doi/10.1073/pnas.1804373115 Chen et al.
in a shift in amount of surface receptor occupancy, which reduces
the accuracy of the response where the ligand concentration is
low. Based on our findings that MAX-1 and AP-3 regulate the
trafficking and degradation of UNC-5 receptor, we can predict
that the guidance of axon is most likely to be affected where the
concentration of UNC-6 is low. Consistent with this prediction,
misguided DA and DB motor axons turn prematurely only in the
dorsal half of max-1 mutants, where UNC-6 is low (10).
Materials and Methods
Details are provided in SI Appendix, SI Materials andMethods, including detailed
methods for yeast two-hybrid screen, C. elegans RNAi experiments, C. elegans
phenotypic analysis, FRAP experiments, in vitro SUMOylation assay, in vitro
binding assay, cell culture and transfection, fluorescence microscope, immuno-
blotting, pulse-chase experiments, coimmunoprecipitation, and statistical analy-
sis. The information about C. elegans strains and the generation of plasmids and
transgene constructs are also described in SI Appendix, SI Materials andMethods.
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